title: [Preparation and properties of folate receptor-targeted cationic liposomes].
abstract: A cationic liposome was prepared with a ligand directed at folate receptor in cancer cells to improve selectivity and facilitate its access to the cancer cells. Folate-polyethyleneglycol-distearoylphosphatidylethanolamine (F-PEG-DSPE) was synthesized by reacting folic acid (F), polyoxyethylene-bis-amine (NH2-PEG-NH2), succinic anhydride (SUC) with distearoylphosphatidylethanolamine (DSPE). Folate receptor-targeted liposomes composed of DPPC/DC-Chol/F-PEG-DSPE (10:10:0.75, molar ratio) were prepared by film dispersion method. A negative charged dextran fluorescein anionic (DFA) was used as a model to explore the in vitro properties and cell uptake efficiencies of liposomal DFA on KB and HpeG2 cells. The formulations were investigated by orthogonal experiment using encapsulation efficiency as the optimized indexes. The size, 4 potential, entrapment efficiency and DFA release in vitro were investigated. The results showed that DFA loaded folate receptor-targeted liposomes had high encapsulation efficiency and the mean size approximately 144 nm. The cationic liposomes had some toxicity to HepG2 cells, and at low concentration (0.0125-0.1 micromol x L(-1)) , the toxicity was linear with the concentration of DC-chol. The folate receptor-targeted liposomes showed great effects on increasing liposome cellular uptake of DFA. In summary, the method of film dispersion method is suitable for producing DFA loaded lipsomes with high entrapment efficiency, small size and slow release. The folate receptor-targeted liposomes can efficiently deliver DFA into cells in vitro. This may represent a promising option for researches on cancer gene therapy.
authors.affiliation: School of Pharmaceutical Science, Peking University, Beijing 100083, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Yan
authors.forename: Xian-Rong
authors.initials: XR
authors.lastname: Qi
mesh_terms: D002352:Carrier Proteins / Q000378:metabolism*; D003911:Dextrans / Q000737:chemistry; D004337:Drug Carriers; D016503:Drug Delivery Systems; D005452:Fluoresceins / Q000737:chemistry; D058973:Folate Receptors, GPI-Anchored; D005492:Folic Acid / Q000737:chemistry*; D015316:Genetic Therapy; D056945:Hep G2 Cells; D006801:Humans; D007624:KB Cells; D008081:Liposomes / Q000008:administration & dosage* / Q000138:chemical synthesis* / Q000378:metabolism; D010316:Particle Size; D010714:Phosphatidylethanolamines / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry; D011956:Receptors, Cell Surface / Q000378:metabolism*; D014162:Transfection
chemical_list: D002352:Carrier Proteins; D003911:Dextrans; D004337:Drug Carriers; D005452:Fluoresceins; D058973:Folate Receptors, GPI-Anchored; D008081:Liposomes; D010714:Phosphatidylethanolamines; D011956:Receptors, Cell Surface; C056350:fluorescein-dextran-amine; C038089:1,2-distearoylphosphatidylethanolamine; D011092:Polyethylene Glycols; D005492:Folic Acid